跳至主要内容
临床试验/NCT07107022
NCT07107022招募中不适用

i-RISE: International Acute Ischemic Stroke Study With the Penumbra System®

Penumbra Inc.10 个研究点 分布在 4 个国家目标入组 200 人开始时间: 2025年11月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Penumbra Inc.
入组人数
200
试验地点
10
主要终点
Outcomes:

研究概览

简要总结

The primary objective of this study is to collect real-world performance and safety data on the Penumbra System in a patient population with acute ischemic stroke (AIS)

详细描述

Post-market, real-world, prospective, single-arm, multi-center study that will enroll up to 200 participants at up to 15 sites globally

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient age 18-80 years
  • Pre-stroke mRS 0-1
  • Patients experiencing acute ischemic stroke who are eligible for mechanical thrombectomy using the Penumbra System
  • Frontline treatment with Penumbra System
  • Signed informed consent per Institution Review Board/Ethics Committee

排除标准

  • Alberta Stroke Program Early CT Score (ASPECTS) ≤6 (for anterior circulation strokes)
  • Any comorbid disease or condition expected to compromise survival or ability to complete follow-up assessments through 90 days
  • Currently participating in an investigational (drug, device, etc.) clinical trial that will influence the endovascular procedure or acute treatment of the patient. Patients in secondary prevention, observational, natural history, and/or
  • epidemiological studies are eligible.
  • Other medical, behavioral, or psychological conditions that in the opinion of the Investigator could limit the patient's ability to participate in the study, including compliance with follow-up requirements, or that could impact the scientific integrity of the study

研究组 & 干预措施

Patients with acute ischemic stroke (AIS)

Device: Penumbra System®

干预措施: Penumbra System ® (Device)

结局指标

主要结局

Outcomes:

时间窗: It is anticipated this study will take approximately 2 years. All participants will be followed for approximately 90-day or to outcome (e.g., withdrawal, death), whichever occurs first.

Angiographic revascularization of the occluded target vessel immediately post- procedure as defined by modified Thrombolysis in Cerebral Infarction (mTICI) 2b or higher Angiographic revascularization of the occluded target vessel immediately post- procedure as defined by mTICI 2c or higher * Angiographic revascularization of the occluded target vessel after the first pass as defined by mTICI 2b or higher * Angiographic revascularization of the occluded target vessel after the first pass as defined by mTICI 2c or higher

次要结局

未报告次要终点

研究者

发起方
Penumbra Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验